(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(tns 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics...
Stats | |
---|---|
Dagens volum | 3 363.00 |
Gjennomsnittsvolum | 86 042.00 |
Markedsverdi | 3.83M |
EPS | $0 ( 2024-04-03 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.190 |
ATR14 | $0.00500 (13.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-27 | Scott John K Jr. | Buy | 64 289 | Series J Convertible Preffered Stock |
2023-11-27 | Scott John K Jr. | Sell | 2 270 | Series G Redeemable Preferred Stock |
2023-11-27 | Scott John K Jr. | Sell | 2 400 | Series I Convertible Preferred Stock |
2023-11-16 | Moss Dana J | Buy | 416 667 | Common Stock |
2023-11-16 | Moss Dana J | Buy | 200 000 | Common Stock |
INSIDER POWER |
---|
99.85 |
Last 95 transactions |
Buy: 26 134 406 | Sell: 71 109 |
Navidea Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Navidea Økonomi
Annual | 2022 |
Omsetning: | $65 652.00 |
Bruttogevinst: | $-119 295 (-181.71 %) |
EPS: | $-0.590 |
FY | 2022 |
Omsetning: | $65 652.00 |
Bruttogevinst: | $-119 295 (-181.71 %) |
EPS: | $-0.590 |
FY | 2021 |
Omsetning: | $45 615.00 |
Bruttogevinst: | $45 615.00 (100.00 %) |
EPS: | $-0.400 |
FY | 2020 |
Omsetning: | $118 725 |
Bruttogevinst: | $117 677 (99.12 %) |
EPS: | $-0.480 |
Financial Reports:
No articles found.
Navidea
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi's sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.